Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XL
326
DELISTED
XL Group Ltd.
XL
| $38.2M | 0.07% |
1,052,110
-707,118
| -40% | -$26.8M |
|
|
CY
327
DELISTED
Cypress Semiconductor
CY
| $38M | 0.07% |
4,458,000
-2,093,274
| -32% | -$22M |
|
328
Regeneron Pharmaceuticals
REGN
$85.9B
| $37.9M | 0.07% |
81,401
+78,079
| +2,350% | +$41.9M |
|
329
Valero Energy
VLO
$100B
| $37.8M | 0.07% |
628,684
+408,103
| +185% | +$25.9M |
|
|
PAY
330
DELISTED
Verifone Systems Inc
PAY
| $37.6M | 0.07% |
1,355,431
+326,297
| +32% | +$10.2M |
|
331
Applied Materials
AMAT
$391B
| $37.6M | 0.07% |
2,556,635
+1,145,822
| +81% | +$19.1M |
|
332
Nexstar Media Group
NXST
$5.73B
| $37.5M | 0.07% |
792,590
+264,262
| +50% | +$13.4M |
|
|
B
333
Barrick Mining
B
$78.3B
| $37.4M | 0.07% |
5,880,138
+5,034,418
| +595% | +$37.9M |
|
334
Chipotle Mexican Grill
CMG
$46.7B
| $37.4M | 0.07% |
2,595,350
-195,450
| -7% | -$2.78M |
|
335
Procter & Gamble
PG
$336B
| $37.1M | 0.07% |
516,068
+56,527
| +12% | +$4.24M |
|
336
L3Harris
LHX
$49.7B
| $37M | 0.07% |
506,203
+142,273
| +39% | +$11.1M |
|
|
THS
337
DELISTED
Treehouse Foods
THS
| $36.9M | 0.07% |
474,322
+333,186
| +236% | +$26.7M |
|
338
Emerson Electric
EMR
$87.7B
| $36.8M | 0.07% |
832,601
+40,649
| +5% | +$2M |
|
|
HES
339
DELISTED
Hess
HES
| $36.7M | 0.07% |
+733,542
| New | +$42M |
|
|
MWE
340
CALL
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $36.7M | 0.07% |
854,900
-542,400
| -39% | -$30.9M |
|
341
PACCAR
PCAR
$69B
| $36.6M | 0.07% |
1,052,895
+175,089
| +20% | +$7.09M |
|
342
Baidu
BIDU
$31.6B
| $36.6M | 0.07% |
266,232
+63,077
| +31% | +$10.4M |
|
343
AutoZone
AZO
$48.3B
| $36.4M | 0.07% |
50,314
-4,294
| -8% | -$3.04M |
|
344
CDW
CDW
$17.2B
| $36.4M | 0.07% |
890,619
-138,593
| -13% | -$5.25M |
|
345
Philip Morris
PM
$293B
| $36.3M | 0.07% |
458,090
-356,814
| -44% | -$29.4M |
|
346
Royal Bank of Canada
RY
$285B
| $35.7M | 0.07% |
646,655
-167,823
| -21% | -$9.56M |
|
|
IM
347
DELISTED
Ingram Micro
IM
| $35.7M | 0.07% |
1,309,471
+1,201,597
| +1,114% | +$31.2M |
|
348
Intercontinental Exchange
ICE
$90.5B
| $35.6M | 0.07% |
757,975
-754,115
| -50% | -$34.9M |
|
349
Eagle Materials
EXP
$6.35B
| $35.5M | 0.07% |
519,247
+348,729
| +205% | +$27.2M |
|
|
AWAY
350
DELISTED
HOMEAWAY INC COM
AWAY
| $35.5M | 0.07% |
+1,336,283
| New | +$39.3M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.